within Pharmacolibrary.Drugs.ATC.N;

model N02AG01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.001,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.1,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0025,
    Tlag           = 600,            
    Vdp             = 0.18,
    k12             = 80,
    k21             = 80
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02AG01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Morphine and antispasmodics (ATC code N02AG01) is a combination product formerly used for the relief of moderate to severe pain associated with conditions featuring muscle spasm, such as renal colic or gastrointestinal spasm. The antispasmodic component is typically a belladonna alkaloid (e.g., atropine, scopolamine). Such fixed-dose combinations are not generally approved or commonly used in modern clinical practice due to the availability of better-tolerated or more specific alternatives.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies reporting PK parameters for the combination product 'morphine and antispasmodics' were found. Parameters are estimated based on known morphine PK after oral administration in healthy adults. Antispasmodic PK not included.</p><h4>References</h4><ol><li><p>van Hoogdalem, E, et al., &amp; Breimer, DD (1991). Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. <i>Clinical pharmacokinetics</i> 21(1) 11–26. DOI:<a href=\"https://doi.org/10.2165/00003088-199121010-00002\">10.2165/00003088-199121010-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1717195/\">https://pubmed.ncbi.nlm.nih.gov/1717195</a></p></li><li><p>Derry, S, et al., &amp; Moore, RA (2017). Aspirin for acute treatment of episodic tension-type headache in adults. <i>The Cochrane database of systematic reviews</i> 1(1) CD011888–None. DOI:<a href=\"https://doi.org/10.1002/14651858.CD011888.pub2\">10.1002/14651858.CD011888.pub2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28084009/\">https://pubmed.ncbi.nlm.nih.gov/28084009</a></p></li><li><p>Gamble, JA, et al., &amp; Dundee, JW (1976). Some pharmacological factors influencing the absorption of diazepam following oral administration. <i>British journal of anaesthesia</i> 48(12) 1181–1185. DOI:<a href=\"https://doi.org/10.1093/bja/48.12.1181\">10.1093/bja/48.12.1181</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1023954/\">https://pubmed.ncbi.nlm.nih.gov/1023954</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02AG01;
